Synopsis of recent research by authors named "Young-Hee Rho"
- Young-Hee Rho's recent research primarily focuses on the biosimilarity and comparative effectiveness of biosimilar drugs in treating autoimmune diseases such as rheumatoid arthritis and conditions like postmenopausal osteoporosis and plaque psoriasis.
- Studies include a phase III trial comparing SB16, a proposed denosumab biosimilar, with the reference product, showing similar effectiveness in postmenopausal women, and another evaluating SB17's similarities to ustekinumab for plaque psoriasis patients.
- Rho's work also encompasses evaluations of the usability and safety of biosimilar administration methods, along with genetic research on inflammatory mediators, indicating a comprehensive approach to understanding biopharmaceuticals in chronic inflammatory conditions.